INtegratioN of Trastuzumab, With or Without Pertuzumab, Into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer: the INNOVATION-TRIAL
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Pertuzumab (Primary) ; Trastuzumab (Primary) ; Capecitabine; Cisplatin; Fluorouracil
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- Acronyms INNOVATION
- 07 Jun 2017 Biomarkers information updated
- 29 Sep 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 03 Aug 2015 Planned End Date changed from 1 Dec 2021 to 1 Sep 2024 as reported by ClinicalTrials.gov.